The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Kingfisher Leads FTSE 100 After Acquisition Setback

Mon, 30th Mar 2015 10:29

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Monday.
-------
FTSE 100 WINNERS
-------
Kingfisher, up 3.2%. The owner of B&Q and Screwfix said its deal to acquire Mr Bricolage will not proceed amid opposition from a shareholder and the board of the French company to the terms of the deal. Kingfisher entered into a deal in July last year to acquire Mr Bricolage for EUR275 million but it warned last week it may be under threat after ANPF, which holds a 41.9% stake in the business, and Mr Bricolage's board had reservations about the deal. Kingfisher said the deadline for gaining anti-trust clearance for the deal in France was March 31 and, as a result of the opposition to the deal from ANPF and the Mr Bricolage board, that deadline is no longer viable.

WPP, up 1.2% at 1,558.64 pence. UBS has lifted the advertising agency price target to 1,700p from 1,500p, reiterating its Buy rating.

Rolls-Royce Holdings, up 1.2%. The jet engine and power turbine company said Air China has selected the British company's Trent 1000 engines and its aftercare support to power 15 new Boeing 787-9 Dreamliner aircraft, building on a relationship the two companies already have and adding to Rolls-Royce's USD1 billion order book.
-------
FTSE 100 LOSERS
-------
CRH, down 1.3%. Eurocement Holding, a key shareholder in Holcim, plans to vote against the Swiss cement maker's merger with Lafarge unless the financial terms of the deal are altered, the Wall Street Journal said Sunday, quoting a person familiar with matter. Eurocement is the second-largest shareholder in Holcim with a 10.82% stake. CRH will acquire a large set of assets from the merged companies.

Wm Morrison Supermarkets, down 1.2% at 196.2p. Goldman Sachs has downgraded the supermarkets chain to Hold from Buy, cutting its price target to 205p from 207p.
-------
FTSE 250 LOSERS
-------
Al-Noor Hospitals Group, down 3.6%. The Abu Dhabi-based healthcare provider shares are down even though it said Monday its pretax profit rose to USD83.9 million from USD61.5 million in 2013, with revenue increasing 23% to USD449.1 million from USD365 million. The group raised its final dividend to 9 pence per share for 2014 to 12.7 pence per share, up 32% year-on-year. However, Numis has downgraded Al Noor Hospitals Group to Hold from Add as the shares have performed well in the run up to the results, but also saying that the consensus for the Abu Dhabi-based healthcare provider's margins is too high.
-------
AIM ALL-SHARE WINNERS
-------
Venn Life Sciences Holdings, up 10%. The company said it has signed contracts worth a total of EUR4.1 million with an unnamed US biotechnology company. Venn Life said the deals are an extension of an existing contract, which has now doubled in size, along with the award of a new clinical trial valued at EUR2.7 million.

Northcote Energy, up 7.6%. The US onshore-focused oil & gas company said it has entered into an agreement with Mexican oilfield and environmental services company Gaia Ecologica, under which the pair will work together on securing new contracts in the country, including oil field services, environmental remediation, waste water treatment to oil and gas development concessions and production sharing agreements. Profits from the joint ventures will be split 51% to Northcote and 49% to Gaia.
-------
AIM ALL-SHARE LOSERS
-------
Quadrise Fuels International, down 19%. The technology provider to the oil and gas industry said its pretax loss in the first half of the financial year widened after it was hit by increased costs and a share option charge, and admitted it has been "frustrating" that it did not progress more of its projects in 2014. The company reported a pretax loss of GBP2.2 million compared with a GBP1.8 million loss a year earlier. The loss widened as production and development costs rose to GBP552,000 from GBP342,000 and after it was hit by a GBP1.1 million share option charge.

Cloudbuy, down 11%. The cloud e-commerce company said its pretax loss widened significantly in 2014 on the back of investments made in its Asia Pacific expansion and due to lower revenue hit by sluggishness in its key markets. CloudBuy said its pretax loss for the year was GBP4.6 million, significantly wider than the GBP936,417 loss it posted a year earlier. The loss was driven by a combination of lower revenue, down to GBP2.1 million from GBP3 million, and by higher administrative expenses related to its expansion and subsequent headcount expansion in Asia Pacific.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
23 Oct 2015 08:17

Venn Life Sciences signs EUR1m contract

(ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company. The AIM listed clinical research organisation announced the deal on Friday. The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and

Read more
23 Oct 2015 06:42

Venn Life Sciences Wins Leukaemia Project Worth Over EUR1 Million

Read more
19 Oct 2015 07:12

Venn Life Sciences Appoints Kinesis Pharma's Groen Executive Director

Read more
22 Sep 2015 15:51

Venn Life posts narrow interim loss, acquires Kinesis

(ShareCast News) - Clinical trial services provider Venn Life Sciences posted a narrower interim pre-tax loss and has agreed to acquire Kinesis Pharma BV. In the six months to the end of June, the London-listed company saw its pre-tax loss narrow from €987,000 (£716,000) to €259,000, while revenue a

Read more
22 Sep 2015 08:35

Venn Life Sciences To Buy Kinesis Pharma As Interim Loss Narrows (ALLISS)

Read more
13 Aug 2015 11:35

Venn Life Sciences reports strong first-half trading

(ShareCast News) - Venn Life sciences said it has had a strong first half, with revenues up 170% on the previous year. In a very brief trading update, the company, which provides clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, reported

Read more
13 Aug 2015 06:45

Venn Life Sciences Says Strong First Half Driven By Contract Wins

Read more
30 Jun 2015 08:31

Venn Life Sciences Sees "Further Solid Trading" In First Half

Read more
30 Jun 2015 07:31

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

Read more
30 Jun 2015 05:16

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 15:11

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 15:13

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 05:20

AGM, EGM Calendar - Week Ahead

Read more
25 Jun 2015 15:30

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.